(DAKT) Daktronics - Overview
Stock: Scoreboards, Video Walls, LED Signs, Transit Displays, Sound
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 50.2% |
| Relative Tail Risk | -10.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.03 |
| Alpha | 33.46 |
| Character TTM | |
|---|---|
| Beta | 1.170 |
| Beta Downside | 1.199 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.00% |
| CAGR/Max DD | 2.08 |
Description: DAKT Daktronics January 26, 2026
Daktronics, Inc. (NASDAQ: DAKT) designs, manufactures, and sells electronic scoreboards, programmable LED display systems, and large-screen video panels for sports venues, commercial locations, and transportation networks worldwide. The business is organized into Commercial, Live Events, High School Park & Recreation, Transportation, and International segments, and it reaches customers through both direct sales forces and a network of authorized resellers.
Recent financials (FY 2025) show revenue of roughly $1.1 billion, a 5 % year-over-year increase, and an operating margin near 9 %. Free cash flow was about $120 million, supporting ongoing R&D and modest dividend payouts. However, the company’s earnings guidance for FY 2026 remains tentative, reflecting lingering uncertainty around silicon-chip pricing and global logistics bottlenecks.
Key market drivers include a projected 10 % CAGR for the global LED-display market through 2030, fueled by expanding out-of-home advertising spend and the modernization of sports-facility scoreboards. In the United States, the 2021 Infrastructure Investment and Jobs Act continues to boost demand for intelligent transportation signage, a segment where Daktronics holds a notable share.
Analysts note that while Daktronics benefits from a diversified end-user base-from retailers and quick-serve restaurants to airlines and municipal transportation agencies-its exposure to cyclical capital-expenditure cycles in the sports and entertainment sectors could introduce earnings volatility.
For a deeper, data-driven valuation, you might explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 7.37m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -0.26 > 1.0 |
| NWC/Revenue: 30.84% < 20% (prev 14.76%; Δ 16.08% < -1%) |
| CFO/TA 0.14 > 3% & CFO 77.5m > Net Income 7.37m |
| Net Debt (30.4m) to EBITDA (42.3m): 0.72 < 3 |
| Current Ratio: 2.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (49.6m) vs 12m ago -4.07% < -2% |
| Gross Margin: 26.85% > 18% (prev 0.26%; Δ 2659 % > 0.5%) |
| Asset Turnover: 140.0% > 50% (prev 148.7%; Δ -8.67% > 0%) |
| Interest Coverage Ratio: 1.92 > 6 (EBITDA TTM 42.3m / Interest Expense TTM 3.23m) |
Altman Z'' 6.70
| A: 0.43 (Total Current Assets 430.2m - Total Current Liabilities 192.6m) / Total Assets 548.4m |
| B: 0.30 (Retained Earnings 161.9m / Total Assets 548.4m) |
| C: 0.01 (EBIT TTM 6.21m / Avg Total Assets 550.1m) |
| D: 2.68 (Book Value of Equity 156.3m / Total Liabilities 58.3m) |
| Altman-Z'' Score: 6.70 = AAA |
Beneish M -3.80
| DSRI: 0.87 (Receivables 129.4m/157.7m, Revenue 770.3m/820.6m) |
| GMI: 0.97 (GM 26.85% / 25.91%) |
| AQI: 0.22 (AQ_t 0.07 / AQ_t-1 0.32) |
| SGI: 0.94 (Revenue 770.3m / 820.6m) |
| TATA: -0.13 (NI 7.37m - CFO 77.5m) / TA 548.4m) |
| Beneish M-Score: -3.80 (Cap -4..+1) = AAA |
What is the price of DAKT shares?
Over the past week, the price has changed by +9.76%, over one month by +22.87%, over three months by +32.00% and over the past year by +54.84%.
Is DAKT a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DAKT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30 | 18.1% |
| Analysts Target Price | 30 | 18.1% |
| ValueRay Target Price | 42.3 | 66.3% |
DAKT Fundamental Data Overview February 04, 2026
P/E Forward = 11.9617
P/S = 1.491
P/B = 3.7972
P/EG = 0.3987
Revenue TTM = 770.3m USD
EBIT TTM = 6.21m USD
EBITDA TTM = 42.3m USD
Long Term Debt = 9.80m USD (from longTermDebt, last quarter)
Short Term Debt = 1.50m USD (from shortTermDebt, last quarter)
Debt = 30.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 30.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.03b USD (1.15b + Debt 30.4m - CCE 149.6m)
Interest Coverage Ratio = 1.92 (Ebit TTM 6.21m / Interest Expense TTM 3.23m)
EV/FCF = 16.68x (Enterprise Value 1.03b / FCF TTM 61.7m)
FCF Yield = 5.99% (FCF TTM 61.7m / Enterprise Value 1.03b)
FCF Margin = 8.01% (FCF TTM 61.7m / Revenue TTM 770.3m)
Net Margin = 0.96% (Net Income TTM 7.37m / Revenue TTM 770.3m)
Gross Margin = 26.85% ((Revenue TTM 770.3m - Cost of Revenue TTM 563.5m) / Revenue TTM)
Gross Margin QoQ = 26.97% (prev 29.72%)
Tobins Q-Ratio = 1.88 (Enterprise Value 1.03b / Total Assets 548.4m)
Interest Expense / Debt = 1.83% (Interest Expense 558.0k / Debt 30.4m)
Taxrate = 20.04% (4.38m / 21.9m)
NOPAT = 4.96m (EBIT 6.21m * (1 - 20.04%))
Current Ratio = 2.23 (Total Current Assets 430.2m / Total Current Liabilities 192.6m)
Debt / Equity = 0.10 (Debt 30.4m / totalStockholderEquity, last quarter 297.5m)
Debt / EBITDA = 0.72 (Net Debt 30.4m / EBITDA 42.3m)
Debt / FCF = 0.49 (Net Debt 30.4m / FCF TTM 61.7m)
Total Stockholder Equity = 280.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.34% (Net Income 7.37m / Total Assets 548.4m)
RoE = 2.63% (Net Income TTM 7.37m / Total Stockholder Equity 280.4m)
RoCE = 2.14% (EBIT 6.21m / Capital Employed (Equity 280.4m + L.T.Debt 9.80m))
RoIC = 1.66% (NOPAT 4.96m / Invested Capital 299.7m)
WACC = 10.00% (E(1.15b)/V(1.18b) * Re(10.23%) + D(30.4m)/V(1.18b) * Rd(1.83%) * (1-Tc(0.20)))
Discount Rate = 10.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.06%
[DCF Debug] Terminal Value 71.05% ; FCFF base≈62.4m ; Y1≈62.2m ; Y5≈65.5m
Fair Price DCF = 16.38 (EV 829.1m - Net Debt 30.4m = Equity 798.7m / Shares 48.7m; r=10.00% [WACC]; 5y FCF grow -0.93% → 2.90% )
EPS Correlation: 33.22 | EPS CAGR: 1.78% | SUE: -2.09 | # QB: 0
Revenue Correlation: 45.04 | Revenue CAGR: 14.15% | SUE: 0.67 | # QB: 0
EPS current Year (2026-04-30): EPS=1.07 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=+27.0% | Growth Revenue=+11.5%
EPS next Year (2027-04-30): EPS=1.21 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+13.1% | Growth Revenue=+7.3%